Abstract:Objectives: To describe the clinical and laboratory features of stage III empyema and to evaluate the effectiveness and safety of using VATS surgery to treat stage III empyema at the Vietnam National Lung hospital. Methods: Propective observational study. From 7/2019 to 01/2020 a total of 58 stage III empyema patients diagnosed who were treated at the Department of Thoracic Surgery – NLH were included in this study. Data were analyzed using SPSS software version 22.0. Results: Among 58 patients with stage III empyema, 39 were treated by total VATS surgery, 19 by VATS as supported procedures. The mean age was 45±19.5 (17-85) years old. Male/female ratio :3.83. The main clinical symptoms were chest pain (81.0%), shortness of breath (70.7%), cough (60.3%). Average surgical time: 127.2±41.6(60- 250) minutes, draining time: 7.5±3 days, hospitalization time 10.3±3.4 (5-22) day. 96.6% of patients discharged with well conditions, confirmed by lung well-expanded lungs on Xrays, the success rate was 94.8%, and there was no patient death. Conclusion: Diagnosing stage III empyema was mainly based on clinical symptoms, chest HRCT. VATS surgery is the safe and effective technique, which helps to reduce surgery time, draining, lying down and reducing pain for patients.

Result of VATS surgery to treat stage III empyema at the Vietnam National Lung hospital